Quick Answer
vTv Therapeutics Inc. reported Cash And Cash Equivalents At Carrying Value of $88.93 million for the year ending 2025.
- vTv Therapeutics Inc. showed an increase of +142.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from vTv Therapeutics Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2014: $1.05 million | Q1 2015: $776.0 thousand | Q2 2015: $2.40 million | Q3 2015: $97.01 million | Q4 2015: $88.00 million | Q1 2016: $75.50 million | Q2 2016: $63.84 million | Q3 2016: $51.06 million | Q1 2017: $45.15 million | Q2 2017: $32.51 million | Q3 2017: $20.49 million | Q1 2018: $6.54 million | Q2 2018: $1.16 million | Q3 2018: $3.77 million | Q1 2019: $4.96 million | Q2 2019: $1.46 million | Q3 2019: $2.44 million | Q1 2020: $406.0 thousand | Q2 2020: $6.39 million | Q3 2020: $1.83 million | Q1 2021: $8.45 million | Q2 2021: $10.84 million | Q3 2021: $19.57 million | Q1 2022: $12.14 million | Q2 2022: $17.86 million | Q3 2022: $15.34 million | Q1 2023: $18.77 million | Q2 2023: $12.60 million | Q3 2023: $8.24 million | Q1 2024: $52.26 million | Q2 2024: $45.53 million | Q3 2024: $41.57 million | Q1 2025: $31.06 million | Q2 2025: $25.92 million | Q3 2025: $98.50 million.
- Over the full 14 years of available data (2012 to 2025), vTv Therapeutics Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 4,087.0%.
- Historical annual values: Fiscal year 2025: $88.93 million | Fiscal year 2024: $36.75 million | Fiscal year 2023: $9.45 million | Fiscal year 2022: $12.13 million | Fiscal year 2021: $13.42 million | Fiscal year 2020: $5.75 million | Fiscal year 2019: $1.78 million | Fiscal year 2018: $1.68 million | Fiscal year 2017: $11.76 million | Fiscal year 2016: $51.51 million | Fiscal year 2015: $88.00 million | Fiscal year 2014: $1.38 million | Fiscal year 2013: $1.09 million | Fiscal year 2012: $2.12 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: